Bob Oliver - 13 Feb 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
13 Feb 2026
Net transactions value
-$1,150,123
Form type
4
Filing time
18 Feb 2026, 20:48:57 UTC
Previous filing
19 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Oliver Bob Director C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA /s/ Nina Ayer, Attorney in Fact 18 Feb 2026 0001694534

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $175,217 +9,088 +21% $19.28 51,370 13 Feb 2026 Direct F1
transaction EXEL Common Stock Sale $396,328 -9,088 -18% $43.61 42,282 13 Feb 2026 Direct F1
transaction EXEL Common Stock Sale $929,012 -21,162 -50% $43.90 21,120 13 Feb 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -9,088 -43% $0.000000 12,118 13 Feb 2026 Common Stock 9,088 $19.28 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.